Needham Small Cap Growth Fund – 4Q22 Commentary

Download PDF

MACRO OBSERVATIONS

  • Inflation expectations have improved significantly, which encourages the Federal Reserve to slow the pace of future interest rate hikes. While energy, food, and labor costs remain a significant headwind to lower inflation, we expect this interest rate rising cycle to end in early 2023. Global economic growth should continue to slow, and the inversion of the interest rate yield curve indicates a higher probability of a global recession.
  • Recent dollar weakness will positively impact corporate earnings of companies that sell overseas, which may lift U.S. equity markets. As we mentioned last year, we needed the dollar to weaken to improve the outlook for U.S. risk assets.
  • Corporate layoffs have accelerated as management teams prepare for a weaker economy and slower business opportunities. While this process is painful for those directly impacted by employment reductions, it is necessary to improve the financial health of the companies and lay the groundwork for the next economic cycle. We expect mergers and acquisitions to increase as companies recognize the impact of higher capital costs and the need for consolidation.
  • Volatility continues as the markets digest earnings and future monetary policy risks. Labor issues, logistical transportation, higher commodity prices, and supply chain constraints have hampered earnings and forward guidance for many companies.
  • Unfortunately, geopolitical risks will persist for an extended period.

IMPACTS ON PORTFOLIO PERFORMANCE

  • The Fund’s Institutional (NESIX) and Retail classes (NESGX) returned 9.90% and 9.68%, respectively, in the fourth quarter, outperforming the Russell 2000 Growth’s 4.13%.
  • Small cap stocks have been in a bear market since March 2021. However, we became more constructive on equities in the fourth quarter of 2022 as equity valuations collapsed, the dollar weakened, and tax loss selling abated in 2023. As we have mentioned previously, small-cap companies should benefit long term as the global economy recovers from its rolling slowdown.
  • Company management teams that can capitalize on revenue prospects should provide leverage in business models and drive earnings and cash flow. Strong balance sheets are extremely important during economic downturns.
  • The Fund’s top five performers were: Benefitfocus, Inc. (BNFT), Infinera Corp. (INFN), Intevac, Inc. (IVAC), Yext, Inc. (YEXT), and Cambium Networks Corp. (CMBM).
  • The Fund’s bottom five performers were: Telos Corp. (TLS), AXT, Inc. (AXTI), Edgio, Inc. (EGIO), Sientra, Inc. (SIEN), and Zuora, Inc. (ZUO).
  • In November 2022, the Fund’s long-time holding Benefitfocus (BNFT) announced its acquisition by Voya Financial. This is a perfect example of a management team that was improving their operations; however, they realized that it is more prudent to consolidate based on economic circumstances and higher costs of capital. We expect more transactions like this one in 2023.

OUTLOOK

  • While many companies still highlight the missing “Golden Screw” to fully finish products, component shortages and overall supply chain challenges have significantly improved. The global economic slowdown has helped improve these headwinds as inventories recover and management teams adjust production lines to minimize future operational disruptions. The reopening of China and the end of the “zero-COVID” approach should also help.
  • We expect the market to ultimately settle out. More reasonable prices should provide interesting entry points for long-term investors to buy high-quality companies with good management and strong balance sheets, earnings, and cash flows. Investment patience and conviction are needed in these volatile and uncertain times.
  • Inflation expectations have substantially improved, which should help alleviate the monetary actions of the Federal Reserve.
  • Semiconductor shortages have had widespread negative implications for many industries, including automotive, medical, industrial, and defense. Recently, we have observed weakness in PC and handsets, which had negative effects on the semiconductor industry. However, we believe that long term, investors will realize value in the sector.
  • The July 2022 passage of the CHIPS and Science Act should drive investment in the semiconductor industry and should also benefit semiconductor capital equipment suppliers.
  • Technology remains a long-term strength of the economy, and there are major secular trends that remain firmly in place to support continued growth in mobile electrification, communications infrastructure, defense, AI, cloud computing, 5G devices and wireless connectivity, software and security, and specialty material manufacturers.

 

The information presented in this commentary is not intended as personalized investment advice and does not constitute a recommendation to buy or sell a particular security or other investments. This message is not an offer of the Needham Growth Fund, the Needham Aggressive Growth Fund or the Needham Small Cap Growth Fund (each a "Fund" and collectively, the "Funds"). Shares are sold only through the currently effective prospectus, which must precede or accompany this report. Please read the prospectus or summary prospectus and carefully consider the investment objectives, risks and charges and expenses of the Funds before you invest. To obtain a copy of the Fund's current prospectus, please visit www.needhamfunds.com or contact the Fund's transfer agent, U.S. Bancorp Fund Services, LLC at 1-800-625-7071.

Investment returns and principal value will fluctuate, and when redeemed, shares may be worth more or less than their original cost. Performance data quoted represents past performance and does not guarantee future results. Current performance may be higher or lower than these results. Performance current to the most recent month-end may be obtained by calling our transfer agent at 1-800-625-7071. Total return figures include reinvestment of all dividends and capital gains.


All three of the Needham Funds have substantial exposure to small and micro capitalized companies. Funds holding smaller capitalized companies are subject to greater price fluctuation than those of larger companies. Needham Small Cap Growth Fund's ownership as a percentage of net assets in the stated securities as of 12/31/22: BNFT: 0.00%, INFN: 3.77%, IVAC: 5.29%, YEXT: 3.66%, CMBM: 3.86%, TLS: 3.11%, AXTI: 2.23%, EGIO: 0.40%, SIEN: 0.07%, ZUO: 2.35%.


The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of MSCI, Inc. and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp FundServices, LLC. The S&P 500 Index is a broad unmanaged measure of the U.S. stock market. The Russell 2000 Index is a broad unmanaged index composed of the smallest 2,000 companies in the Russell 3000 Index. The Russell 2000 Growth Index includes those Russell 2000 Index companies with higher price-to-value ratios and higher forecasted growth values. An investor cannot invest directly in an index. Needham & Company, LLC is a wholly owned subsidiary of The Needham Group, Inc. Needham & Company, LLC, member FINRA/SIPC, is the distributor of The Needham Funds, Inc.


The source of the data for each of the Russell 2000 Index and the Russell 3000 Index (together, the “Indexes”) is the London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2022. All rights in the Indexes vest in the relevant LSE Group company which owns the Index. The Indexes are calculated by or on behalf of FTSE International Limited or its affiliate, agent or partner. Neither the LSE Group nor its licensors accept any liability for any errors or omissions in the Indexes; no party may rely on the Index returns shown; and the LSE Group makes no claim, prediction, warranty or representation about the Fund or the suitability of the Indexes with respect to the Fund. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group is not connected to the Fund and does not promote, sponsor or endorse the Fund or the content of this prospectus.